We are live on
!
Find out more
RSS
Rosenblum Silverman Sutton Portfolio holdings
AUM
$382M
1-Year Est. Return
13.82%
This Fund
S&P 500
This Quarter
Est. Return
+8.07%
1 Year Est. Return
+13.82%
3 Year Est. Return
+95.36%
5 Year Est. Return
+122.03%
10 Year Est. Return
+858.24%
AUM
$250M
AUM Growth
+$14M
(+5.9%)
Cap. Flow
-$2.46M
Cap. Flow
% of AUM
-0.98%
Top 10 Holdings %
Top 10 Hldgs %
39.49%
Holding
66
New
3
Increased
30
Reduced
20
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$4.56M |
| 2 |
COL
Rockwell Collins
COL
|
+$4.06M |
| 3 |
Insulet
PODD
|
+$1.8M |
| 4 |
Alibaba
BABA
|
+$1.49M |
| 5 |
TLND
Talend S.A. American Depositary Shares
TLND
|
+$735K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aecom
ACM
|
+$4.65M |
| 2 |
NVIDIA
NVDA
|
+$4.33M |
| 3 |
MBLY
Mobileye N.V.
MBLY
|
+$3.72M |
| 4 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
+$2.45M |
| 5 |
Acuity Brands
AYI
|
+$1.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.59% |
| 2 | Consumer Discretionary | 16.22% |
| 3 | Healthcare | 15.56% |
| 4 | Communication Services | 13.68% |
| 5 | Financials | 12.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Morgan Stanley
MS
$339B
| $1.08M | 0.43% |
24,257
+1,550
| +7% | +$66.8K |
|
52
Aclaris Therapeutics
ACRS
$793M
| $1.04M | 0.42% |
38,400
+5,650
| +17% | +$154K |
|
|
GTT
53
DELISTED
GTT Communications, Inc.
GTT
| $957K | 0.38% |
30,230
+19,630
| +185% | +$582K |
|
54
RTX Corp
RTX
$261B
| $949K | 0.38% |
12,354
+619
| +5% | +$46.4K |
|
|
TLND
55
DELISTED
Talend S.A. American Depositary Shares
TLND
| $784K | 0.31% |
+22,550
| New | +$735K |
|
56
Brunswick
BC
$5.23B
| $711K | 0.28% |
11,330
| – | – |
|
57
S&P Global
SPGI
$133B
| $654K | 0.26% |
4,479
| – | – |
|
58
Comfort Systems
FIX
$58.9B
| $430K | 0.17% |
11,600
| – | – |
|
|
EGRX
59
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $368K | 0.15% |
4,665
+400
| +9% | +$32.7K |
|
60
Berkshire Hathaway Class B
BRK.B
$1.06T
| $301K | 0.12% |
1,780
| – | – |
|
61
3M
MMM
$83.4B
| $295K | 0.12% |
1,692
| – | – |
|
|
62
Aecom
ACM
$8.78B
| – | – |
-130,610
| Closed | -$4.65M |
|
63
Gilead Sciences
GILD
$167B
| – | – |
-9,945
| Closed | -$675K |
|
|
MBLY
64
DELISTED
Mobileye N.V.
MBLY
| – | – |
-60,545
| Closed | -$3.72M |
|
|
ZLTQ
65
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| – | – |
-44,110
| Closed | -$2.45M |
|
Similar funds
STP
LWM
DSA
RC
NFP
MADR
MVP
BFP
Rosenblum Silverman Sutton's Q2 2017 Portfolio in Review
As of Q2 2017, Rosenblum Silverman Sutton held 66 positions worth $250M, up 5.9% from $236M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Rosenblum Silverman Sutton's Q2 2017 filing shows 3 new, 30 increased, 20 reduced and 4 closed positions. Its largest new stake was Rockwell Collins: 39,210 shares worth $4.12M. The largest sale was Aecom, an estimated $4.65M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Rosenblum Silverman Sutton's largest Q2 2017 buy was Rockwell Collins: 39,210 shares worth $4.12M.
- Rosenblum Silverman Sutton added most to DexCom in Q2 2017, an estimated $4.56M increase.
- Rosenblum Silverman Sutton's biggest Q2 2017 reduction was NVIDIA, cutting an estimated $4.33M.
- Rosenblum Silverman Sutton fully exited Aecom in Q2 2017, selling an estimated $4.65M.
- Rosenblum Silverman Sutton's ten largest holdings make up 39% of its $250M portfolio in Q2 2017.
- Rosenblum Silverman Sutton opened 3 new positions and closed 4 in Q2 2017.
- Rosenblum Silverman Sutton's portfolio value rose 5.9% quarter-over-quarter to $250M.
Based on Rosenblum Silverman Sutton's 13F filing for Q2 2017, filed 9 Aug 2017.